OLIPASS CORPORATION Logo

OLIPASS CORPORATION

Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.

244460 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 동백중앙로16번길 16-4 에이스동백타워1동 20층, 용인시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

OLIPASS CORPORATION is a biotechnology company focused on the research and development of RNA therapeutics. The company's core technology is its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. This platform utilizes a modified PNA with covalently attached cationic lipid groups, which significantly enhances cell permeability. OPNA is designed to induce exon skipping by specifically binding to target pre-mRNA within the cell nucleus. This mechanism enables the development of a pipeline of novel therapeutic drug candidates for various diseases. The company's vision is to become a leading global R&D company in the field of RNA therapeutics.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for OLIPASS CORPORATION and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-15 00:00
Regulatory News Service
[기재정정]투자판단관련주요경영사항 (신약 공동연구개발 연구개발비 수령)
Korean 11.7 KB
2025-09-15 00:00
Regulatory News Service
[기재정정]투자판단관련주요경영사항 (신약 공동연구개발 연구개발비 수령)
Korean 11.3 KB
2025-09-15 00:00
Regulatory News Service
[기재정정]투자판단관련주요경영사항 (신약 공동연구개발 연구개발비 수령)
Korean 10.7 KB
2025-09-12 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 16.1 KB
2025-09-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 63.1 KB

Automate Your Workflow. Get a real-time feed of all OLIPASS CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OLIPASS CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan 7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.